Houston-first directory · 6 checked local clinicians · No patient lead forms
pPEPTIDE HEALTHDIRECTORY & EVIDENCE NOTES
Source-linked monitoring

FDA shortage tracker

Package-level source records for the 67 compounds in our library. Not a stock finder, treatment menu or compounding eligibility check.

FDA dataset checked

Dataset date: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT. All 1581 source records retrieved.

Daily sync is enabled. The source date and last completed retrieval above show freshness.

openFDA warns not to rely on its data for medical-care decisions. No matching record is Unknown, not proof that a drug is available. Resolved and discontinued records do not establish stock. Read the FDA source and consult a licensed clinician.

FDA dataset documentation · FDA API · FDA Drug Shortages database

67 matching entries. Reset

5-Amino-1MQ (related non-peptide)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Abaloparatide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

AICAR (related non-peptide)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

AOD-9604

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

ARA-290 / cibinetide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Ascorbic acid IV (ASCOR)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

BPC-157

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Cagrilintide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Cagrilintide + semaglutide (CagriSema)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Cathelicidin LL-37

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

CJC-1295

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Compounded hormone preparations

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Compounded products are not FDA-approved

Source records and history · Evidence note

Desmopressin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Dextrose + sodium chloride

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Dihexa acetate

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Dulaglutide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Elamipretide / SS-31

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Emideltide (DSIP)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Epitalon

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Estradiol

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Estradiol + progesterone

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Exenatide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

FOXO4-DRI

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

GHK-Cu

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Glutathione

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Compounding / no product-approval claim

Source records and history · Evidence note

Growth hormone releasing peptide-2 (GHRP-2)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Growth hormone releasing peptide-6 (GHRP-6)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Hexarelin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Humanin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Ibutamoren mesylate

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

IGF-1 LR3

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Ipamorelin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Kisspeptin-10

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

KPV

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Lactated Ringer's solution

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Lanreotide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Levocarnitine (L-carnitine)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Linaclotide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Liraglutide

FDA current shortage record

FDA lists a current shortage for at least one matched product/package. Other presentations may differ; this is not a pharmacy inventory check.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Magnesium sulfate IV

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Mazdutide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Mecasermin (IGF-1 prescription product)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Mechano growth factor pegylated (PEG-MGF)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Melanotan II

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

MOTS-c

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

NAD+

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Compounding / no product-approval claim

Source records and history · Evidence note

Octreotide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Oxytocin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Pramlintide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Progesterone

Discontinuation / mixed records

Matched records include discontinuation notices or mixed non-current states. Check each package; no compound-wide stock conclusion is made.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

PT-141 / Bremelanotide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Retatrutide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Selank

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Semaglutide

Discontinuation / mixed records

Matched records include discontinuation notices or mixed non-current states. Check each package; no compound-wide stock conclusion is made.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context; compounded versions not approved

Source records and history · Evidence note

Semax

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Sermorelin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Historical approval context

Source records and history · Evidence note

SLU-PP-332 (related non-peptide)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

Sodium chloride IV solution

Discontinuation / mixed records

Matched records include discontinuation notices or mixed non-current states. Check each package; no compound-wide stock conclusion is made.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Survodutide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Investigational / no FDA-approved-treatment claim

Source records and history · Evidence note

TB-500

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Teduglutide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Teriparatide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Tesamorelin

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Prescription-product label context

Source records and history · Evidence note

Testosterone cypionate

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Thiamine injection (vitamin B1)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context

Source records and history · Evidence note

Thymosin-alpha 1 (Ta1)

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: Research / no approved-treatment claim

Source records and history · Evidence note

Tirzepatide

Unknown

Unknown: no exact single-substance FDA shortage record matched. Absence from the dataset is not proof of availability or approval.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Regulatory context: FDA-approved product context; compounded versions not approved

Source records and history · Evidence note